Robert Wasserman

Stock Analyst at Benchmark

(3.31)
# 938
Out of 4,898 analysts
113
Total ratings
44.44%
Success rate
3.9%
Average return

Stocks Rated by Robert Wasserman

Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $52.62
Upside: +42.53%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $7.75
Upside: +93.55%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $2.06
Upside: +191.97%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150$140
Current: $119.66
Upside: +17.00%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $27.55
Upside: +27.04%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $1.98
Upside: +51.52%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.24
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $57.65
Upside: +30.10%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $22.00
Upside: +36.36%
Anebulo Pharmaceuticals
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.69
Upside: +373.37%
Reiterates: Speculative Buy
Price Target: $5
Current: $3.70
Upside: +35.30%
Maintains: Buy
Price Target: $8$12
Current: $7.30
Upside: +64.38%
Reiterates: Hold
Price Target: n/a
Current: $3.08
Upside: -
Reiterates: Hold
Price Target: n/a
Current: $121.33
Upside: -
Reiterates: Speculative Buy
Price Target: $12
Current: $0.34
Upside: +3,482.09%
Reiterates: Buy
Price Target: $45
Current: $40.19
Upside: +11.97%
Reiterates: Speculative Buy
Price Target: $4
Current: $4.55
Upside: -12.09%
Reiterates: Speculative Buy
Price Target: $4
Current: $0.21
Upside: +1,766.54%
Reiterates: Speculative Buy
Price Target: $75
Current: $1.95
Upside: +3,746.15%
Downgrades: Hold
Price Target: n/a
Current: $197.75
Upside: -
Initiates: Buy
Price Target: $580
Current: $425.34
Upside: +36.36%